Cargando…
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study
PURPOSE: Weight regain after bariatric surgery occurs in up to a third of patients and reduces treatment-associated health benefits. The efficacy of glucagon-like peptide-1 receptor agonists (GLP1-RA) for treatment of type 2 diabetes mellitus and obesity is well established, but their role in the tr...
Autores principales: | Jensen, Anders Boisen, Renström, Frida, Aczél, Stefan, Folie, Patrick, Biraima-Steinemann, Magdalena, Beuschlein, Felix, Bilz, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9918402/ https://www.ncbi.nlm.nih.gov/pubmed/36765019 http://dx.doi.org/10.1007/s11695-023-06484-8 |
Ejemplares similares
-
The Potential of Semaglutide Once-Weekly in Patients Without Type 2 Diabetes with Weight Regain or Insufficient Weight Loss After Bariatric Surgery—a Retrospective Analysis
por: Lautenbach, Anne, et al.
Publicado: (2022) -
Patients’ Experiences of Weight Regain After Bariatric Surgery
por: Tolvanen, Liisa, et al.
Publicado: (2022) -
The Discovery and Development of Liraglutide and Semaglutide
por: Knudsen, Lotte Bjerre, et al.
Publicado: (2019) -
Reversal of Long-Term Weight Regain After Roux-en-Y Gastric Bypass Using Liraglutide or Surgical Revision. A Prospective Study
por: Horber, Fritz F., et al.
Publicado: (2020) -
Perceived and Preferred Social Support in Patients Experiencing Weight Regain After Bariatric Surgery—a Qualitative Study
por: Tolvanen, Liisa, et al.
Publicado: (2020)